The protocol describes the detailed steps for treating patients with giant esophageal leiomyoma (GEL, > 10 cm) and achieving complete resection safely and effectively using endoscopic submucosal tunneling and resection.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Case Report
The protocol describes the detailed steps for treating patients with giant esophageal leiomyoma (GEL, > 10 cm) and achieving complete resection safely and effectively using endoscopic submucosal tunneling and resection.
Esophageal leiomyoma is a common benign tumor of the esophagus. Traditionally, surgical resection is performed for large lesions. In this case, a 19-year-old male patient with a GEL underwent three-dimensional volume rendering to assess the surrounding structures, followed by submucosal tunneling and resection (STER). A modified arc-shaped mucosal incision was designed to provide sufficient exposure for dissection and complete removal of the lesion. Postoperative pathology confirmed leiomyoma. The patient resumed oral intake on postoperative day 2 and was discharged on day 5. STER creates a submucosal tunnel between the mucosal and muscular layers of the digestive tract and is mainly used for removing small esophageal and cardia submucosal tumors originating from the muscularis propria. It offers several advantages, including a short operation time, minimal trauma, rapid recovery, and no visible scars. In this case, STER was successfully applied to remove a large lesion, indicating that endoscopic treatment of GEL is both safe and feasible. However, further experience is required to evaluate its long-term efficacy.
Giant esophageal leiomyoma is generally defined as a tumor measuring ≥10 cm in diameter and represents a rare benign neoplasm arising from the muscularis propria of the esophagus1,2. Although most esophageal leiomyomas exhibit indolent growth and minimal malignant potential, large tumors may cause progressive dysphagia, retrosternal discomfort, and even compression of adjacent mediastinal structures, rendering management technically demanding. Conventional treatment consists of open thoracotomy or thoracoscopic enucleation, and in selected cases partial esophagectomy. While these approaches provide relia....
Access restricted. Please log in or start a trial to view this content.
The patient provided written informed consent for the use of medical data. This manuscript reports a single clinical case and does not involve prospective clinical study, retrospective cohort analysis, or any experimental intervention beyond routine clinical management. Written informed consent for publication was obtained from the patient prior to manuscript submission. Therefore, there is no specific IRB approval number applicable to this report
1. Preoperative examination and resectability assessment
Access restricted. Please log in or start a trial to view this content.
The surgery was successfully completed, and the specimen was completely removed. The total operation time was 150 min. The nasogastric tube was removed 24 h postoperatively, and a liquid diet gradually started. The patient was discharged smoothly on POD5. Postoperative chest CT suggested complete resection of the esophageal lesion. Pathology revealed leiomyoma, and immunohistochemical staining showed H-cald and α-SMA (diffuse+), CD117, Dog1, and CD34(-), Ki-67 (<1%+), SDH-B(-), PHH3 (mitotic figures <2/50HPF), and .......
Access restricted. Please log in or start a trial to view this content.
Esophageal leiomyoma is a common benign esophageal tumor, usually solitary, and mostly occurs in the middle and lower esophagus. Dysphagia, pain, and weight loss are the most common clinical manifestations6. Extremely rare esophageal leiomyomas grow to >10 cm and are called giant esophageal leiomyomas (GELs)2,7. Most GEL patients experience symptoms such as dysphagia and chest tightness. In this case, the patient presented with dysphag.......
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest.
The authors have no acknowledgments.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 1.5-mm Disposable mucosal incision knife | Anrei, HangZhou, China | EK-410D | |
| A transparent cap | Top Corporation, Tokyo, Japan | Elastic Touch F-030 | |
| Endoscopic image processing device | Olympus (Japan) | CV-290 | |
| High Frequency Electrotome | Erbe, Tübingen, Germany | VIO 200 D | |
| High-frequency hemostatic forceps | Olympus (Japan) | FD-410LR | |
| metal clips | AGS, HangZhou, China | 16mm,AG-51044-1950-135-16 | |
| Single Use Injector | MICRO-TECH(Nanjing) | IN02-25423230 | |
| Snare Master | MT, NanJing, China | MTN-PFS-A-28/23 | |
| standard gastroscope | Olympus | GIF-260J |
Access restricted. Please log in or start a trial to view this content.